{
 "meta": {
  "publisher": "GLP-1 Tirzepatide Rx",
  "records": 64,
  "unrecorded_sources": 0,
  "by_source_class": {
   "primary \u2014 provider or manufacturer published material, verified directly": 11,
   "secondary \u2014 third-party review, not verified with the provider": 18,
   "no price published \u2014 entity tracked, no figure claimed": 12,
   "primary \u2014 client data export": 3,
   "primary \u2014 published trial report": 20
  },
  "by_verification_level": {
   "source-verified": 14,
   "no-price-published": 21,
   "third-party-reported": 9
  },
  "verification_note": "source-verified = read from the provider, manufacturer or a named editorial source with a stated date. third-party-reported = recorded from a supplied third-party review, not confirmed with the provider. no-price-published = no interpretable figure exists; we publish none.",
  "warning": "Records marked 'unrecorded' have no traceable source in our dataset and should be treated as unverified until one is attached.",
  "last_verified": "2026-08-05"
 },
 "manifest": [
  {
   "record": "providers/trimrx",
   "source": "TrimRx published pricing as captured June-August 2026: compounded tirzepatide $349/month flat at every dose; multi-month plans billed as one total, 12 months at $3,518 (about $293/month). Compounded semaglutide $199/month injectable. Accessed 2026-08-05.",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/yucca-health",
   "source": "GLP-1 Watchdog, 'Cheapest Compounded Tirzepatide Online' (23 May 2026) and its live price rail. Secondary source: a third-party round-up, not confirmed against the provider's own published material.",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/skinnyrx",
   "source": "skinnyrx.com published pricing, verified April 2026 and consistent with the company's December 2025 and February 2026 press releases: compounded injectable tirzepatide and tirzepatide tablets from $299/month, compounded injectable semaglutide from $199/month, no membership fee for compounded medication. Accessed 2026-08-05.",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/medvi",
   "source": "GLP-1 Watchdog, 'Cheapest Compounded Tirzepatide Online' (23 May 2026) and its live price rail. Secondary source: a third-party round-up, not confirmed against the provider's own published material.",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/oak-longevity",
   "source": "oaklovesyou.com homepage pricing, accessed 2026-08-05: compounded tirzepatide from $199/month and compounded semaglutide from $133/month, with no subscription. Operated by Leaf Longevity Holdings Corp. trading as Oak Longevity.",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/mochi-health",
   "source": "joinmochi.com pricing FAQ and compounded-tirzepatide page, accessed 2026-08-05; corroborated by U.S. News (6 May 2026) and Mira Health (Jul 2026). $79/mo membership plus $199/mo medication, flat across the published dose range, equals $278 all-in.",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": false,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/henry-meds",
   "source": "No single figure could be verified. Published third-party figures for compounded tirzepatide ranged from $169/mo to $297/mo introductory and $429-$549/mo maintenance across sources checked 2026-08-05.",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/nexlife",
   "source": "nexlife.us plan pages, accessed 2026-08-05 \u2014 tirzepatide-all-plans, sublingual-tirzepatide-odt and microdose-tirzepatide-program, plus the matching semaglutide pages. Tirzepatide injection $215 monthly, $195 on 3 months, $190 on 6 and $186 on 12, flat across the full 2.5-15 mg titration. Pharmacy partners and Medical Director named on-site.",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": false,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/ivim-health",
   "source": "Ivim Health help-centre pricing article (updated 2026-07-01) and ivimhealth.com/glp1-pricing, accessed 2026-08-05; corroborated by U.S. News. Compounded tirzepatide from $133/mo plus a required $74.99/mo membership, about $208 all-in at the entry dose.",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/orderlymeds",
   "source": "No published price we could verify as of 2026-08-05.",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/hims-hers",
   "source": "GLP-1 Tirzepatide Rank data export; market status from FDA statements and secondary coverage",
   "source_type": "primary \u2014 client data export",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/ro-body",
   "source": "GLP-1 Tirzepatide Rank data export; corroborated by Policy Lab, 28 Jul 2026",
   "source_type": "primary \u2014 client data export",
   "conflict_noted": true,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/noom-med",
   "source": "GLP-1 Tirzepatide Rank data export; corroborated by Policy Lab, 28 Jul 2026",
   "source_type": "primary \u2014 client data export",
   "conflict_noted": true,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/lillydirect",
   "source": "Eli Lilly investor press release on Zepbound single-dose vial pricing and the LillyDirect Self Pay Journey Program tiers effective 23 Feb 2026, accessed 2026-08-05.",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/novocare",
   "source": "GLP-1 Watchdog channel-pricing table (23 May 2026), published by a third-party round-up. Secondary source, not verified with Novo Nordisk.",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/bmi-md",
   "source": "Policy Lab provider review, refreshed 28 Jul 2026 (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/onlinesemaglutide",
   "source": "Policy Lab provider review, refreshed 28 Jul 2026 (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/reflexmd",
   "source": "Policy Lab provider review, refreshed 28 Jul 2026 (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/mystart-health",
   "source": "Policy Lab provider review, refreshed 28 Jul 2026 (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/ivyrx",
   "source": "Policy Lab provider review, refreshed 28 Jul 2026 (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/shedrx",
   "source": "Policy Lab provider review, refreshed 28 Jul 2026 (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/gala-health",
   "source": "GLP-1 Watchdog price rail and Policy Lab review (secondary sources)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/sprout-health",
   "source": "GLP-1 Watchdog price rail (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/bodybuilding-health",
   "source": "Policy Lab review and GLP-1 Watchdog rail (secondary sources)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/eden-health",
   "source": "eden.health pricing disclosure, accessed 2026-08-05: medication price excludes a required Eden membership at $39 for the first month, auto-renewing at $99/month. Third-party reviews place compounded tirzepatide at $196-$249/month medication-only.",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/willow",
   "source": "GLP-1 Watchdog provider index (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/strut-health",
   "source": "GLP-1 Watchdog provider index (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "source-verified",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/direct-meds",
   "source": "GLP-1 Watchdog provider index (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/zealthy",
   "source": "GLP-1 Watchdog provider index (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": true,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/fridays",
   "source": "GLP-1 Watchdog provider index (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/found",
   "source": "GLP-1 Watchdog provider index (secondary source)",
   "source_type": "secondary \u2014 third-party review, not verified with the provider",
   "conflict_noted": false,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/lifemd",
   "source": "U.S. News & World Report provider review (accessed 2026-08-05); membership tiers as reported there",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": false,
   "verification": "third-party-reported",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/weightwatchers-clinic",
   "source": "WeightWatchers official site (accessed 2026-08-05) and secondary review coverage",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": true,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/calibrate",
   "source": "Secondary provider comparisons (accessed 2026-08-05)",
   "source_type": "primary \u2014 provider or manufacturer published material, verified directly",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/form-health",
   "source": "Tracked entity; no price we could verify as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/sesame-care",
   "source": "Tracked entity; no single price exists to verify as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/plushcare",
   "source": "Tracked entity; no verified GLP-1 medication price as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/hone-health",
   "source": "Entity tracked from a third-party provider index; no price verified as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/fella-health",
   "source": "Entity tracked from a third-party provider index; no price verified as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/peter-md",
   "source": "Entity tracked from a third-party provider index; no price verified as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/agelessrx",
   "source": "Entity tracked from a third-party provider index; no price verified as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/weightcare",
   "source": "Named in FDA enforcement reporting reviewed 2026-08-05; no price verified",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": true,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/wellorithm",
   "source": "Entity tracked from a third-party provider index; no price verified as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "providers/telos-rx",
   "source": "Entity tracked from a third-party provider index; no price verified as of 2026-08-05",
   "source_type": "no price published \u2014 entity tracked, no figure claimed",
   "conflict_noted": false,
   "verification": "no-price-published",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surmount-1",
   "source": "N Engl J Med 2022;387:205-216",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT04184622",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surmount-5",
   "source": "N Engl J Med 2025;392:1929-1942",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT05822830",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surmount-4",
   "source": "JAMA 2024;331:38-48",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT04660643",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surmount-osa",
   "source": "N Engl J Med 2024;391:1193-1205",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT05412004",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surpass-2",
   "source": "N Engl J Med 2021;385:503-515",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT03987919",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surpass-cvot",
   "source": "N Engl J Med 2025 (presented ADA 2025)",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT04255433",
   "verified": "2026-08-05"
  },
  {
   "record": "science/summit",
   "source": "N Engl J Med 2025;392:427-437",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT04847557",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surmount-3",
   "source": "Nat Med 2023;29:2909-2918",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT04657016",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surmount-2",
   "source": "Lancet 2023;402:613-626",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT04657003",
   "verified": "2026-08-05"
  },
  {
   "record": "science/attain-1",
   "source": "N Engl J Med 2025 / FDA approval April 2026",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT05869903",
   "verified": "2026-08-05"
  },
  {
   "record": "science/step-1",
   "source": "N Engl J Med 2021;384:989-1002",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT03548935",
   "verified": "2026-08-05"
  },
  {
   "record": "science/select",
   "source": "N Engl J Med 2023;389:2221-2232",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT03574597",
   "verified": "2026-08-05"
  },
  {
   "record": "science/step-8",
   "source": "JAMA 2022;327:138-150",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT03611582",
   "verified": "2026-08-05"
  },
  {
   "record": "science/gip-mechanism",
   "source": "Reviews in Cell Metab / Nat Rev Endocrinol 2023\u20132025",
   "source_type": "primary \u2014 published trial report",
   "registration": "\u2014",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surpass-1",
   "source": "Lancet 2021;398:143-155",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT03954834",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surpass-3",
   "source": "Lancet 2021;398:583-598",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT03882970",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surpass-4",
   "source": "Lancet 2021;398:1811-1824",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT03730662",
   "verified": "2026-08-05"
  },
  {
   "record": "science/surpass-j-mono",
   "source": "Lancet Diabetes Endocrinol 2022;10:623-633",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT03861052",
   "verified": "2026-08-05"
  },
  {
   "record": "science/tirzepatide-cv-meta",
   "source": "Nat Med 2022;28:591-598",
   "source_type": "primary \u2014 published trial report",
   "registration": "Not applicable \u2014 pre-specified meta-analysis of registered trials",
   "verified": "2026-08-05"
  },
  {
   "record": "science/time-to-plateau",
   "source": "Clin Obes 2025",
   "source_type": "primary \u2014 published trial report",
   "registration": "NCT04184622 and NCT04660643",
   "verified": "2026-08-05"
  }
 ]
}